Siegfried Holding AG (SWX: SFZN)

Market Cap	4.23B
Revenue (ttm)	1.28B
Net Income (ttm)	128.86M
Shares Out	4.29M
EPS (ttm)	29.78
PE Ratio	33.15
Forward PE	27.07
Dividend	3.60 (0.36%)
Ex-Dividend Date	May 3, 2024

Volume	7,252
Average Volume	6,751
Open	977.00
Previous Close	974.00
Day's Range	970.00 - 983.00
52-Week Range	831.50 - 1,188.00
Beta	0.72
RSI	43.10
Earnings Date	Feb 18, 2025

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic fi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 4,070
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2023, Siegfried Holding AG's revenue was 1.27 billion, an increase of 3.41% compared to the previous year's 1.23 billion. Earnings were 112.69 million, a decrease of -27.99%.